A 67-year-old woman with a previous non-ST elevation myocardial infarction and drug-eluting stent 3 months ago is seen in follow-up. She is on atorvas...

Question

A 67-year-old woman with a previous non-ST elevation myocardial infarction and drug-eluting stent 3 months ago is seen in follow-up. She is on atorvastatin 40 mg nightly, along with dual antiplatelet therapy. Her fasting LDL-C is 1.9 mmol/L. According to CCS lipid guidelines, which is the most appropriate lipid management?

Accepted Answer

Continue current high-intensity statin therapy

Answer

Stop statin therapy as her LDL-C is at goal

Answer

Switch to a low-intensity statin to reduce myopathy risk

Answer

Add ezetimibe and target LDL-C below 0.5 mmol/L

Answer

Substitute a PCSK9 inhibitor for the statin

ca-mccqe1 MCQ (SBA): Secondary prevention dyslipidaemia